|
Model Number 3387 |
Device Problems
Break (1069); Malposition of Device (2616); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erosion (1750); Hematoma (1884); Intracranial Hemorrhage (1891); Muscle Weakness (1967); Paresis (1998); Cognitive Changes (2551); Confusion/ Disorientation (2553); Ptosis (2620); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/04/2022 |
Event Type
malfunction
|
Event Description
|
Simsek erdem n, ozkaynak ss, cakin h, ucar t.Surgical-related and hardware-related adverse effects of deep brain stimulation: a ret rospective single-center analysis.Turk neurosurg.2021.10.5137/1019-5149.Jtn.32559-20.4.All patients who underwent dbs electrode implantation at the akdeniz university hospital during the last five years participated in this study.Demographic information (sex, age, diagnosis, the duration between diagnosis and surgery, comorbid disease) and the date of surgery were collected from an electronic medical database.The adverse effects of dbs were classified into two: surgery-related and hardware-related effects, which were further subdivided based on whether they occurred intraoperatively, in the early postoperative stage, or over a long period time.Reported events: one patient experienced electrode fracture which occurred during a reposition surgery after it was determined there was malposition of the lead during the implant.The lead was replaced and the issue was resolved.
|
|
Manufacturer Narrative
|
Other relevant device(s) are: product id: 37601, serial/lot #: unknown, product id: 37601, serial/lot #: unknown, product id: 37601, serial/lot #: unknown.Please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 37601 lot# serial# unknown implanted: explanted: product type implantable neurostimulator product id 37601 lot# serial# unknown implanted: explanted: product type implantable neurostimulator product id 37601 lot# serial# unknown implanted: explanted: product type implantable neurostimulator product id 37601 lot# serial# unknown implanted: explanted: product type implantable neurostimulator medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|